Literature DB >> 27935376

Mesenchymal Stem Cells Modulate Light-induced Activation of Retinal Microglia Through CX3CL1/CX3CR1 Signaling.

Libin Huang1, Guoxing Xu1, Jian Guo1, Maosong Xie1, Lisha Chen1, Wei Xu1.   

Abstract

PURPOSE: To evaluate the effect of CX3CL1/CX3CR1 signaling on the interaction between mesenchymal stem cells (MSCs) and retinal microglia.
METHODS: Supernatants of homogenized retina were harvested from light-damaged SD rats (ISHR) to stimulated retinal microglia. Stimulated microglia were cocultured with MSCs, CX3CL1 over-expressing MSCs (CX3CL1-MSCs) or CX3CL1-blocked MSCs (anti-CX3CL1-MSCs) for 24 hours, and their molecular and functional changes were examined. Moreover, soluble CX3CL1 was directly added to microglia cultures.
RESULTS: ISHR stimulation activated retinal microglia. MSCs coculture inhibited the protein expression of pro-inflammatory factors by activated microglia, increased the protein expression of neurotrophic factors, and was accompanied with upregulation of CX3CR1. Meanwhile, MSCs suppressed proliferative and migratory function of activated microglia, but promoted the phagocytic capability. These effects were strengthened by CX3CL1- MSCs, and reversed by anti-CX3CL1-MSCs. Soluble CX3CL1 could enhanced microglial migration.
CONCLUSIONS: MSCs might restore homeostatic functions of retinal microglia responded to light damage mainly through CX3CL1/CX3CR1 signaling.

Entities:  

Keywords:  Mesenchymal stem cells; chemokines CX3CL1; inflammation; microglia; retinal degeneration

Mesh:

Substances:

Year:  2015        PMID: 27935376     DOI: 10.3109/09273948.2015.1071405

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  7 in total

1.  Over-expression of CNTF in bone marrow mesenchymal stem cells protects RPE cells from short-wavelength, blue-light injury.

Authors:  Wen Lin; Guoxing Xu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-03-21       Impact factor: 2.416

2.  Organoid-derived C-Kit+/SSEA4- human retinal progenitor cells promote a protective retinal microenvironment during transplantation in rodents.

Authors:  Ting Zou; Lixiong Gao; Yuxiao Zeng; Qiyou Li; Yijian Li; Siyu Chen; Xisu Hu; Xi Chen; Caiyun Fu; Haiwei Xu; Zheng Qin Yin
Journal:  Nat Commun       Date:  2019-03-14       Impact factor: 14.919

Review 3.  The secretion profile of mesenchymal stem cells and potential applications in treating human diseases.

Authors:  Yuyi Han; Jianxin Yang; Jiankai Fang; Yipeng Zhou; Eleonora Candi; Jihong Wang; Dong Hua; Changshun Shao; Yufang Shi
Journal:  Signal Transduct Target Ther       Date:  2022-03-21

4.  CX3CL1 Derived from Bone Marrow Mesenchymal Stem Cells Inhibits Aβ 1-42-Induced SH-SY5Y Cell Pathological Damage through TXNIP/NLRP3 Signaling Pathway.

Authors:  Chuan Guo; Qinxuan Li; Jiujia Xiao; Xuhui Zhou; Meichen Tian; Lei Xie; Xun Xia
Journal:  Comput Math Methods Med       Date:  2022-09-08       Impact factor: 2.809

5.  Interleukin-13 Gene Modification Enhances Grafted Mesenchymal Stem Cells Survival After Subretinal Transplantation.

Authors:  Libin Huang; Junmei You; Yao Yao; Maosong Xie
Journal:  Cell Mol Neurobiol       Date:  2019-12-02       Impact factor: 5.046

6.  3D MALDI mass spectrometry imaging reveals specific localization of long-chain acylcarnitines within a 10-day time window of spinal cord injury.

Authors:  Jusal Quanico; Lena Hauberg-Lotte; Stephanie Devaux; Zahra Laouby; Celine Meriaux; Antonella Raffo-Romero; Melanie Rose; Leia Westerheide; Jost Vehmeyer; Franck Rodet; Peter Maass; Dasa Cizkova; Norbert Zilka; Veronika Cubinkova; Isabelle Fournier; Michel Salzet
Journal:  Sci Rep       Date:  2018-10-31       Impact factor: 4.379

7.  MSC Secretome as a Promising Tool for Neuroprotection and Neuroregeneration in a Model of Intracerebral Hemorrhage.

Authors:  Maxim Karagyaur; Stalik Dzhauari; Nataliya Basalova; Natalia Aleksandrushkina; Georgy Sagaradze; Natalia Danilova; Pavel Malkov; Vladimir Popov; Mariya Skryabina; Anastasia Efimenko; Vsevolod Tkachuk
Journal:  Pharmaceutics       Date:  2021-11-29       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.